Based on recent 2026 financial reports, Elevance Health (formerly known as Anthem, Inc.) maintains a market capitalization of approximately $132 billion to $145 billion. As one of the largest health insurers in the United States, its "net worth" is best measured by its total shareholder equity, which currently stands at roughly $41.5 billion, supported by annual revenues exceeding $185 billion.
The term "Anthem’s net worth" is frequently used by the public to describe the financial valuation of Elevance Health, the corporate giant that rebranded from Anthem, Inc. in 2022. While the name "Anthem" survives as a primary brand for its Blue Cross Blue Shield licensed plans, the parent company’s valuation is driven by its massive footprint in the Medicare Advantage, commercial insurance, and health services sectors (Carelon). As of early 2026, the company’s financial trajectory remains robust, characterized by steady membership growth and the successful integration of its pharmacy benefit management (PBM) services.
Understanding the Rebranding: From Anthem to Elevance Health
To accurately discuss Anthem’s net worth in 2026, it is essential to distinguish between the brand name and the legal corporate entity. In June 2022, Anthem, Inc. officially changed its name to Elevance Health, Inc. This shift was not merely a cosmetic update but a strategic move to signal the company’s evolution beyond traditional health insurance into a comprehensive health services organization.
The "Anthem" name remains one of the most valuable intangible assets in the company’s portfolio. It serves as the consumer-facing brand for health plans in 14 states where the company holds Blue Cross Blue Shield licenses. In recent reports, the valuation of the Anthem brand itself is estimated in the billions, contributing significantly to the company's overall market position. However, for investors and analysts looking at "net worth," the focus is on Elevance Health's consolidated balance sheet.
Current Market Capitalization and Shareholder Equity (2026)
In the corporate world, "net worth" is typically translated as Shareholder Equity (total assets minus total liabilities). However, in the context of search intent, most users are interested in the Market Capitalization—what the market believes the company is worth.
Shareholder Equity vs. Market Value
As of the latest quarterly filings in 2026, Elevance Health reports total assets of approximately $115 billion. These assets include cash equivalents, premium receivables, and long-term investments. After accounting for liabilities—largely consisting of medical claims reserves and long-term debt—the total shareholder equity sits near $41.5 billion.
Conversely, the market capitalization (the total value of all outstanding shares) has fluctuated between $130 billion and $150 billion throughout 2025 and into 2026. This "premium" over the book value reflects investor confidence in the company’s ability to generate future cash flows through its diverse portfolio of health services.
Stock Performance and Valuation Ratios
In 2026, Elevance Health (traded under the ticker ELV) has maintained a relatively stable Price-to-Earnings (P/E) ratio, often hovering between 14x and 17x. This stability is a key indicator of its perceived value within the managed healthcare industry, positioning it as a "Blue Chip" stock with defensive qualities during market volatility.
Revenue Streams: The Engines of Anthem’s Valuation
The "net worth" of a healthcare giant is sustained by its revenue-generating capacity. Recent reports highlight three primary segments that drive the company’s financial health:
1. Health Benefits (Commercial and Government)
This remains the core of the business. By 2026, Elevance Health serves more than 50 million members. The growth in the Medicare Advantage (MA) sector has been a significant driver of the company’s valuation. Despite regulatory changes in 2024 and 2025 regarding MA star ratings and reimbursement rates, Anthem’s diversified geographic presence has allowed it to maintain strong profit margins.
2. Carelon (Health Services)
Carelon is the brand encompassing the company’s health services, including pharmacy benefit management (CarelonRx), behavioral health, and complex care delivery. Carelon’s contribution to the total net worth has grown exponentially. By 2026, Carelon accounts for nearly 25% to 30% of the company’s overall operating gain, reducing the company's reliance on traditional insurance premiums.
3. Wellpoint (State-Sponsored Programs)
The Wellpoint brand focuses on Medicaid and other state-sponsored programs. Following the "unwinding" of the Medicaid continuous enrollment provision in 2024, the company successfully stabilized its Medicaid membership in 2025 and 2026, contributing to a more predictable revenue stream.
Comparative Financial Analysis: 2024–2026
To understand the current "net worth" of Anthem (Elevance Health), it is helpful to look at the progression of key financial metrics over the last three fiscal years.
| Metric | 2024 (Actual) | 2025 (Estimated) | 2026 (Projected/Recent) |
|---|---|---|---|
| Total Revenue | $171.3 Billion | $182.5 Billion | $191.0 Billion |
| Net Income | $6.2 Billion | $6.8 Billion | $7.4 Billion |
| Market Capitalization | $112 Billion | $128 Billion | $138 Billion |
| Total Shareholder Equity | $37.8 Billion | $39.5 Billion | $41.5 Billion |
| Earnings Per Share (EPS) | $26.40 | $33.10 | $37.20 |
Data sourced from Elevance Health Investor Relations and consolidated SEC filings.
Factors Influencing Valuation in the Current Market
Several external and internal factors have shaped Anthem’s net worth and market reports in 2026. Understanding these provides context for why the company is valued at its current level.
Regulatory and Legislative Impacts
The healthcare landscape in 2026 is heavily influenced by federal policies regarding the Inflation Reduction Act (IRA) and its impact on prescription drug pricing. Elevance Health, through CarelonRx, has had to navigate these changes meticulously. The company's ability to maintain high Medicare Advantage star ratings has also been a direct contributor to its valuation, as these ratings dictate bonus payments from the Centers for Medicare & Medicaid Services (CMS).
Technological Integration and AI
Recent reports frequently cite the company’s investment in "whole health" platforms driven by Artificial Intelligence (AI). By automating claims processing and utilizing predictive analytics for patient care, Elevance has reduced its administrative cost ratio. This operational efficiency is a primary reason why its market valuation remains high relative to its physical assets.
Strategic Acquisitions
Between 2024 and 2026, the company pursued targeted acquisitions in home health care and specialized pharmacy services. These acquisitions are integrated into the Carelon brand, expanding the company’s "moat" and increasing the lifetime value of each insured member.
Risks and Challenges to Net Worth
No financial analysis is complete without considering the headwinds. While Anthem/Elevance Health is a financial powerhouse, its net worth is subject to several risks:
- Medical Loss Ratio (MLR) Volatility: In 2026, rising costs of labor in the clinical sector and increased utilization of elective procedures have put pressure on the MLR (the percentage of premiums spent on actual medical care). A higher MLR typically results in lower net income and a potential dip in stock valuation.
- Antitrust Scrutiny: As the company expands its Carelon division, it faces increased scrutiny from the Department of Justice (DOJ) regarding vertical integration. Any regulatory action to decouple insurance from pharmacy services would significantly impact the company’s market cap.
- Cybersecurity Costs: As a holder of millions of sensitive medical records, the company faces ongoing threats. Major data breaches can lead to massive settlements and long-term damage to the brand’s intangible value.
The Valuation of "Anthem" as a Musical Entity
While the insurance company is the primary subject of "net worth" reports, there is a secondary niche interest in the valuation of National Anthems and Anthemic Music Catalogs.
In the music industry, "anthems" refer to high-value, evergreen song catalogs (e.g., works by Queen, Journey, or nationalistic hymns). In 2026, the market for music publishing rights remains a multi-billion dollar industry. Investment firms like Hipgnosis and Blackstone continue to report on the "net worth" of these catalogs, which are valued based on their annual royalty yield. A top-tier "anthem" catalog can be worth anywhere from $200 million to $500 million, depending on synchronization rights and streaming performance. However, this is a distinct financial sector from the multi-billion dollar healthcare entity.
Expert Guidance: Verifying Financial Data
For those tracking the net worth of Anthem (Elevance Health) for investment or research purposes, it is vital to use verified sources. The company’s financial status is not a static number but a fluctuating market value.
- SEC EDGAR Database: Access the latest 10-K (Annual Report) and 10-Q (Quarterly Report) for Elevance Health, Inc. These provide the most accurate "book value" and shareholder equity figures.
- Investor Relations Portal: Elevance Health provides comprehensive "Fact Sheets" that break down revenue by segment (Commercial, Government, Carelon).
- Third-Party Analysts: Reports from firms like Goldman Sachs, Morgan Stanley, and Morningstar provide "Fair Value" estimates which often differ from current market prices.
FAQs About Anthem’s Net Worth
Is Anthem still the name of the company?
The parent company is now Elevance Health. However, the company continues to use the Anthem Blue Cross and Anthem Blue Cross and Blue Shield names for its health insurance plans in 14 states. In recent reports, the "net worth" of the parent company encompasses all its brands, including Anthem, Wellpoint, and Carelon.
How much does the CEO of Anthem make?
As of 2026 reports, Gail Boudreaux, the CEO of Elevance Health, typically receives a total compensation package valued between $20 million and $25 million annually. This includes a base salary, stock options, and performance-based incentives. Her personal net worth is estimated to be in the hundreds of millions, largely tied to ELV stock performance.
How does Anthem’s net worth compare to UnitedHealth Group?
UnitedHealth Group (UHG) remains the largest competitor. In 2026, UHG has a market capitalization of over $500 billion, making it significantly larger than Elevance Health (~$140 billion). While Anthem is a market leader, it occupies the "second-tier" of healthcare giants alongside Cigna and CVS Health (Aetna).
What is the profit margin for Anthem in 2026?
Elevance Health typically maintains a net profit margin of approximately 3.5% to 4.5%. While this may seem low compared to tech companies, the sheer volume of revenue (approaching $200 billion) results in billions of dollars in annual profit, which sustains the company’s high valuation.
Does Anthem's net worth include its real estate?
Yes, the total assets reported on the balance sheet include the company’s corporate headquarters in Indianapolis and various regional offices. However, the majority of the company's "worth" is derived from its investment portfolio (bonds and equities used to back insurance claims) and its intangible "goodwill" from acquisitions.
Final Recommendation
For those interested in the financial standing of Anthem (Elevance Health) in 2026, the most critical figure to monitor is the Carelon segment’s growth. While the insurance side provides a stable foundation, the company’s long-term "net worth" and market premium are increasingly tied to its ability to provide health services and pharmacy management. Investors should prioritize reviewing the Operating Margin by Segment in the most recent quarterly reports to determine if the company is successfully diversifying away from the highly regulated insurance premium model.